Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Advancements In Biotechnology
3.1.2. Growth In Prenatal Testing
3.1.3. Rise In Direct-To-Consumer Genetic Testing
3.1.4. Genetic Testing Helps In Determining Medication Dosage
3.2. Key Restraints
3.2.1. Expensive Cost Of Treatment
3.2.2. Government Regulation And Legislation

4. Key Analytics
4.1. Impact Of Covid-19 On Genetic Testing Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.8. Regulatory Framework

5. Market By Type
5.1. Prenatal And Newborn Testing
5.2. Diagnostic Testing
5.3. Predictive & Presymptomatic Testing
5.4. Carrier Testing
5.5. Pharmacogenomic Testing
5.6. Other Types

6. Market By Technology
6.1. Molecular Testing
6.2. Cytogenetic Testing
6.3. Biochemical Testing

7. Market By Application
7.1. Genetic Disease Diagnosis
7.2. Cancer Diagnosis
7.3. Cardiovascular Disease Diagnosis
7.4. Other Applications

8. Market By Disease
8.1. Cancer
8.2. Cystic Fibrosis
8.3. Huntington’S Disease
8.4. Sickle Cell Anaemia
8.5. Duchenne Muscular Dystrophy
8.6. Alzheimer’S Disease
8.7. Rare Diseases
8.8. Thalassemia
8.9. Other Diseases

9. Geographical Analysis
9.1. North America
9.1.1. Market Size & Estimates
9.1.2. Key Growth Enablers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United States
9.1.5.2. Canada

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions & Divestitures
10.2. Company Profiles
10.2.1. 23&Me Inc
10.2.2. Abbott Laboratories
10.2.3. Bgi Group
10.2.4. Bio-Rad Laboratories
10.2.5. Csl Limited
10.2.6. Decode Genetics
10.2.7. Elitech Group
10.2.8. Eurofins Scientific
10.2.9. Illumina Inc
10.2.10. Luminex Corporation
10.2.11. Myriad Genetics Inc
10.2.12. Perkinelmer Inc
10.2.13. Qiagen
10.2.14. Quest Diagnostics Inc
10.2.15. Roche Diagnostics Inc




List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Value Chain Analysis
Figure 6: North America Genetic Testing Market, Growth Potential, By Type, In 2021
Figure 7: North America Genetic Testing Market, By Prenatal And Newborn Testing Genetic Testing, 2022-2030 (In $ Million)
Figure 8: North America Genetic Testing Market, By Diagnostic Testing, 2022-2030 (In $ Million)
Figure 9: North America Carrier Testing Market, By Carrier Testing, 2022-2030 (In $ Million)
Figure 10: North America Genetic Testing Market, By Pharmacogenomic Testing, 2022-2030 (In $ Million)
Figure 11: North America Genetic Testing Market, Growth Potential, By Technology, In 2021
Figure 12: North America Genetic Testing Market, By Molecular Testing, 2022-2030 (In $ Million)
Figure 13: North America Genetic Testing Market, By Cytogenetic Testing, 2022-2030 (In $ Million)
Figure 14: North America Genetic Testing Market, By Biochemical Testing, 2022-2030 (In $ Million)
Figure 15: North America Genetic Testing Market, Growth Potential, By Application, In 2021
Figure 16: North America Genetic Testing Market, By Genetic Disease Diagnosis, 2022-2030 (In $ Million)
Figure 17: North America Genetic Testing Market, By Cancer Diagnosis, 2022-2030 (In $ Million)
Figure 18: North America Genetic Testing Market, By Cardiovascular Diseases Diagnosis, 2022-2030 (In $ Million)
Figure 19: North America Genetic Testing Market, By Other Applications, 2022-2030 (In $ Million)
Figure 20: North America Genetic Testing Market, Growth Potential, By Disease, In 2021
Figure 21: North America Genetic Testing Market, By Cancer, 2022-2030 (In $ Million)
Figure 22: North America Genetic Testing Market, By Cystic Fibrosis, 2022-2030 (In $ Million)
Figure 23: North America Genetic Testing Market, By Huntington’S Disease, 2022-2030 (In $ Million)
Figure 24: North America Genetic Testing Market, Sickle Cell Anemia, 2022-2030 (In $ Million)
Figure 25: North America Genetic Testing Market, By Duchenne Muscular Dystrophy, 2022-2030 (In $ Million)
Figure 26: North America Genetic Testing Market, By Alzheimer’S Disease, 2022-2030 (In $ Million)
Figure 27: North America Genetic Testing Market, By Rare Diseases, 2022-2030 (In $ Million)
Figure 28: North America Genetic Testing Market, By Thalassemia, 2022-2030 (In $ Million)
Figure 29: North America Genetic Testing Market, By Other Diseases, 2022-2030 (In $ Million)
Figure 30: North America Genetic Testing Market, Country Outlook, 2021 & 2030 (In %)
Figure 31: United States Genetic Testing Market, 2022-2030 (In $ Million)
Figure 32: Canada Genetic Testing Market, 2022-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - GENETIC TESTING
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: NORTH AMERICA GENETIC TESTING MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: NORTH AMERICA GENETIC TESTING MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: NORTH AMERICA GENETIC TESTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: NORTH AMERICA GENETIC TESTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: NORTH AMERICA GENETIC TESTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: NORTH AMERICA GENETIC TESTING MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA GENETIC TESTING MARKET, BY DISEASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: NORTH AMERICA GENETIC TESTING MARKET, BY DISEASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: LEADING PLAYERS OPERATING IN NORTH AMERICA GENETIC TESTING MARKET
TABLE 14: LIST OF MERGERS & ACQUISITIONS
TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES